Every year, RIVM provides an overview of surveillance and developments in the National Immunisation Programme (NIP).

RIVM has conducted an explorative study on the use of point-of-care (POC) tests in nursing homes.

In personalised medicine, patients are treated with medicinal products according to their individual characteristics, such as genetic background, instead of a traditional one-size-fits-all approach

Measurements by thousands of citizen scientists in the Netherlands using their smartphones and the iSPEX add-on are delivering accurate data on fine air particles in the atmosphere that add valuabl

In safeguarding the quality, safety and efficacy of medicinal products, the present EU regulatory system has become a time consuming and highly regulated process.

The Medicines Evaluation Board (MEB), the Netherlands Pharmacovigilance Centre (Lareb), the National Institute for Public Health and the Environment (RIVM), and the National Health Care Institute w

The average annual disease burden for the total Dutch population was highest for invasive pneumococcal disease and influenza.

As 21 days have passed since the two aid workers evacuated from Sierra Leone had unprotected contact with Ebola patients, active monitoring of their health status by the Community Health Service ha

On the first day of the 17th European Health Forum Gastein (EHFG), the Dutch National Institute for Public Health and the Environment (RIVM) organises a workshop on ‘Our health in 2040’.

The two patients, who have been admitted to the hospital under suspicion of an Ebola infection, are not infected with the virus.